Incidence of gastroenteropancreatic neuroendocrine tumours: A systematic review of the literature

Endocrine-Related Cancer

Volumn 21, Issue 3, 2014, Pages

  Fraenkel, M ^a   Kim, M ^b   Faggiano, A ^c,d   De Herder, W W ^e   Valk, G D ^f  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b MOUNT SINAI MEDICAL CENTER   (United States)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d NATIONAL CANCER INSTITUTE   (Italy)

^e ERASMUS MEDICAL CENTER   (Netherlands)

^f UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Carcinoids; Epidemiology; Incidence; Neuroendocrine tumours

Indexed keywords

CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER REGISTRY; DATA BASE; GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR; GENDER; HUMAN; RACE DIFFERENCE; RECTUM; REVIEW; SMALL INTESTINE; SYSTEMATIC REVIEW; UNITED KINGDOM; UNITED STATES; EPIDEMIOLOGY; EUROPE; INCIDENCE; INTESTINAL NEOPLASMS; JAPAN; LITERATURE; NEUROENDOCRINE TUMORS; PANCREATIC NEOPLASMS; STOMACH NEOPLASMS;

EUROPE; HUMANS; INCIDENCE; INTESTINAL NEOPLASMS; JAPAN; NEUROENDOCRINE TUMORS; PANCREATIC NEOPLASMS; REVIEW LITERATURE AS TOPIC; STOMACH NEOPLASMS; UNITED STATES;

EID: 84903618224     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1530/ERC-13-0125     Document Type: Review

References (49)

1. Ballantyne GH, Savoca PE, Flannery JT, Ahlman MH & Modlin IM 1992 Incidence and mortality of carcinoids of the colon. Data from the Connecticut Tumor Registry. Cancer 69 2400-2405. (doi:10.1002/1097-0142(19920515)69: 10〈2400::AID-CNCR2820691003〉3.0.CO;2-Z)
2. Berge T & Linell F 1976 Carcinoid tumours. Frequency in a defined population during a 12-year period. Acta Pathologica, Microbiologica, et Immunologica Scandinavica 84 322-330.
3. Bilimoria KY, Bentrem DJ, Wayne JD, Ko CY, Bennett CL & Talamonti MS 2009 Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years. Annals of Surgery 249 63-71. (doi:10.1097/SLA.0b013e31818e4641)
4. Buchanan KD, Johnston CF, O'Hare MM, Ardill JE, Shaw C, Collins JS, Watson RG, Atkinson AB, Hadden DR, Kennedy TL et al. 1986 Neuroendocrine tumors. A European view. American Journal of Medicine 81 14-22. (doi:10.1016/0002- 9343(86)90581-4)
5. Caldarella A, Crocetti E & Paci E 2011 Distribution, incidence, and prognosis in neuroendocrine tumors: a population based study from a cancer registry. Pathology Oncology Research 17 759-763. (doi:10.1007/s12253-011-9382- y)
6. Chow JS, Chen CC, Ahsan H & Neugut AI 1996 A population-based study of the incidence of malignant small bowel tumours: SEER, 1973-1990. International Journal of Epidemiology 25 722-728. (doi:10.1093/ije/25.4.722)
7. Crocetti E & Paci E 2003 Malignant carcinoids in the USA, SEER 1992-1999. An epidemiological study with 6830 cases. European Journal of Cancer Prevention 12 191-194. (doi:10.1097/00008469-200306000-00004) (Pubitemid 36683754)
8. Crocetti E, Buiatti E & Amorosi A 1997 Epidemiology of carcinoid tumours in central Italy. European Journal of Epidemiology 13 357-359. (doi:10.1023/A:1007334217762) (Pubitemid 27306085)
9. Ellis L, Shale MJ & Coleman MP 2010 Carcinoid tumors of the gastrointestinal tract: trends in incidence in England since 1971. American Journal of Gastroenterology 105 2563-2569. (doi:10.1038/ajg.2010.341)
10. Garcia-Carbonero R, Capdevila J, Crespo-Herrero G, Díaz- Pérez JA, Martínez Del Prado MP, Alonso Orduña V, Sevilla-García I, Villabona-Artero C, Beguiristain-Gómez A, Llanos-MuñozMet al. 2010 Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE). Annals of Oncology 21 1794-1803. (doi:10.1093/annonc/mdq022)
11. Godwin JD II 1975 Carcinoid tumors. An analysis of 2,837 cases. Cancer 36 560-569. (doi:10.1002/1097-0142(197508)36:2〈560::AIDCNCR2820360235〉3. 0. CO;2-4)
12. Gustafsson BI, Siddique L,Chan A, Dong M, Drozdov I, Kidd M&Modlin IM 2008 Uncommon cancers of the small intestine, appendix and colon: an analysis of SEER 1973-2004, and current diagnosis and therapy. International Journal of Oncology 33 1121-1131.
13. Halfdanarson TR, Rabe KG, Rubin J & Petersen GM 2008 Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival. Annals of Oncology 19 1727-1733. (doi:10.1093/annonc/mdn351)
14. Hauso O, Gustafsson BI, Kidd M, Waldum HL, Drozdov I, Chan AK & Modlin IM 2008 Neuroendocrine tumor epidemiology: contrasting Norway and North America. Cancer 113 2655-2664. (doi:10.1002/cncr.23883)
15. Hemminki K & Li X 2001 Incidence trends and risk factors of carcinoid tumors: a nationwide epidemiologic study from Sweden. Cancer 92 2204-2210. (doi:10.1002/1097-0142(20011015)92:8〈2204::AIDCNCR1564〉3.0.CO;2-R)
16. Hodgson N, Koniaris LG, Livingstone AS & Franceschi D 2005 Gastric carcinoids: a temporal increase with proton pump introduction. Surgical Endoscopy 19 1610-1612. (doi:10.1007/s00464-005-0232-4) (Pubitemid 41719529)
17. Ito T, Sasano H, Tanaka M, Osamura RY, Sasaki I, Kimura W, Takano K, Obara T, Ishibashi M, Nakao K et al. 2010 Epidemiological study of gastroenteropancreatic neuroendocrine tumors in Japan. Journal of Gastroenterology 45 234-243. (doi:10.1007/s00535-009-0194-8)
18. Klimstra DS, Modlin IR, Adsay NV, Chetty R, Deshpande V, Gönen M, Jensen RT, Kidd M, Kulke MH, Lloyd RV et al. 2010a Pathology reporting of neuroendocrine tumors: application of the Delphic consensus process to the development of a minimum pathology data set. American Journal of Surgical Pathology 34 300-313. (doi:10.1097/PAS.0b013e3181ce1447)
19. Klimstra DS, Modlin IR, Coppola D, Lloyd RV & Suster S 2010b The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems. Pancreas 39 707-712. (doi:10.1097/MPA. 0b013e3181ec124e)
20. Klöppel G 2011 Classification and pathology of gastroenteropancreatic neuroendocrine neoplasms. Endocrine-Related Cancer 18 (Suppl 1) S1-S16. (doi:10.1530/ERC-11-0013)
21. Klöppel G, Couvelard A, Perren A, Komminoth P, McNicol AM, Nilsson O, Scarpa A, Scoazec JY, Wiedenmann B, Papotti M et al. 2009 ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification. Neuroendocrinology 90 162-166. (doi:10.1159/000182196)
22. Klöppel G, Rindi G, Perren A, Komminoth P & Klimstra DS 2010 The ENETS and AJCC/UICC TNM classifications of the neuroendocrine tumors of the gastrointestinal tract and the pancreas: a statement. Virchows Archiv 456 595-597. (doi:10.1007/s00428-010-0924-6)
23. Kwekkeboom DJ, Krenning EP, Lebtahi R, Komminoth P, Kos-Kudła B, de Herder WW, Plöckinger U & Mallorca Consensus Conference participants; European Neuroendocrine Tumor Society 2009 ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: peptide receptor radionuclide therapy with radiolabeled somatostatin analogs. Neuroendocrinology 90 220-226. (doi:10.1159/000225951)
24. Landerholm K, Falkmer S & Järhult J 2010 Epidemiology of small bowel carcinoids in a defined population. World Journal of Surgery 34 1500-1505. (doi:10.1007/s00268-010-0519-z)
25. Lawrence B, Gustafsson BI, Chan A, Svejda B, Kidd M & Modlin IM 2011 The epidemiology of gastroenteropancreatic neuroendocrine tumors. Endocrinology and Metabolism Clinics of North America 40 1-18. (doi:10.1016/j.ecl.2010.12.005)
26. Lepage C, Bouvier AM, Phelip JM, Hatem C, Vernet C & Faivre J 2004 Incidence and management of malignant digestive endocrine tumours in a well defined French population. Gut 53 549-553. (doi:10.1136/gut.2003.026401) (Pubitemid 38372980)
27. Lepage C, Bouvier AM, Manfredi S, Dancourt V & Faivre J 2006 Incidence and management of primary malignant small bowel cancers: a welldefined French population study. American Journal of Gastroenterology 101 2826-2832. (doi:10.1111/j.1572-0241.2006.00854.x) (Pubitemid 44902657)
28. Levi F, Randimbison L, Franceschi S & La Vecchia C 1993 Descriptive epidemiology of malignant carcinoids in the Swiss Canton of Vaud. International Journal of Cancer 53 1036-1037. (doi:10.1002/ijc. 2910530630)
29. Levi F, Te VC, Randimbison L, Rindi G & La Vecchia C 2000 Epidemiology of carcinoid neoplasms in Vaud, Switzerland, 1974-97. British Journal of Cancer 83 952-955. (doi:10.1054/bjoc.2000.1394)
30. Li AF, Hsu CY, Li A, Tai LC, Liang WY, Li WY, Tsay SH & Chen JY 2008 A 35-year retrospective study of carcinoid tumors in Taiwan: differences in distribution with a high probability of associated second primary malignancies. Cancer 112 274-283. (doi:10.1002/cncr.23159)
31. Lombard-Bohas C, Mitry E, O'Toole D, Louvet C, Pillon D, Cadiot G, Borson-Chazot F, Aparicio T, Ducreux M, Lecomte T et al. 2009 Thirteen-month registration of patients with gastroenteropancreatic endocrine tumours in France. Neuroendocrinology 89 217-222. (doi:10.1159/000151562)
32. Maggard MA, O'Connell JB & Ko CY 2004 Updated population-based review of carcinoid tumors. Annals of Surgery 240 117-122. (doi:10.1097/01.sla. 0000129342.67174.67) (Pubitemid 38808243)
33. Modlin IM & Sandor A 1997 An analysis of 8305 cases of carcinoid tumors. Cancer 79 813-829. (doi:10.1002/(SICI)1097-0142(19970215)79:4 〈813::AID-CNCR19〉3.0.CO;2-2)
34. Modlin IM, Sandor A, Tang LH, Kidd M & Zelterman D 1997 A 40-year analysis of 265 gastric carcinoids. American Journal of Gastroenterology 92 633-638. (Pubitemid 27184378)
35. Modlin IM, Lye KD & Kidd M 2003 A 5-decade analysis of 13,715 carcinoid tumors. Cancer 97 934-959. (doi:10.1002/cncr.11105)
36. Modlin IM, Lye KD & Kidd M 2004 A 50-year analysis of 562 gastric carcinoids: small tumor or larger problem? American Journal of Gastroenterology 99 23-32. (doi:10.1046/j.1572-0241.2003.04027.x)
37. Modlin IM, Champaneria MC, Chan AK & Kidd M 2007 A three-decade analysis of 3,911 small intestinal neuroendocrine tumors: the rapid pace of no progress. American Journal of Gastroenterology 102 1464-1473. (doi:10.1111/j.1572-0241.2007.01185.x)
38. Newton JN, Swerdlow AJ, dos Santos Silva IM, Vessey MP, Grahame-Smith DG, Primatesta P & Reynolds DJ 1994 The epidemiology of carcinoid tumours in England and Scotland. British Journal of Cancer 70 939-942. (doi:10.1038/bjc. 1994.424) (Pubitemid 24331090)
39. Niederle MB, Hackl M, Kaserer K & Niederle B 2010 Gastroenteropancreatic neuroendocrine tumours: the current incidence and staging based on theWHOand European Neuroendocrine Tumour Society classification: an analysis based on prospectively collected parameters. Endocrine-Related Cancer 17 909-918. (doi:10.1677/ERC-10-0152)
40. Oberndorfer S 1907 Karzinoide tumoren des dünndarms. Frankfurter Zeitschrift för Pathologie 1 426-432.
41. Ploeckinger U, Kloeppel G, Wiedenmann B, Lohmann R & representatives of 21 German NET Centers 2009 The German NETregistry: an audit on the diagnosis and therapy of neuroendocrine tumors. Neuroendocrinology 90 349-363. (doi:10.1159/000242109)
42. Quaedvlieg PF, Visser O, Lamers CB, Janssen-Heijen ML & Taal BG 2001 Epidemiology and survival in patients with carcinoid disease in The Netherlands. An epidemiological study with 2391 patients. Annals of Oncology 12 1295-1300. (doi:10.1023/A:1012272314550) (Pubitemid 32994760)
43. Severson RK, SchenkM, Gurney JG, Weiss LK & Demers RY 1996 Increasing incidence of adenocarcinomas and carcinoid tumors of the small intestine in adults. Cancer Epidemiology, Biomarkers & Prevention 5 81-84.
44. Sundin A, Vullierme MP, Kaltsas G, Plöckinger U & Mallorca Consensus Conference participants; European Neuroendocrine Tumor Society 2009 ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: radiological examinations. Neuroendocrinology 90 167-183. (doi:10.1159/ 000184855)
45. Watson RG, Johnston CF, O'Hare MM, Anderson JR, Wilson BG, Collins JS, Sloan JM & Buchanan KD 1989 The frequency of gastrointestinal endocrine tumours in a well-defined population-Northern Ireland 1970-1985. Quarterly Journal of Medicine 72 647-657. (Pubitemid 19188550)
46. Westergaard T, Frisch M & Melbye M 1995 Carcinoid tumors in Denmark 1978-1989 and the risk of subsequent cancers. A population-based study. Cancer 76 106-109. (doi:10.1002/1097-0142(19950701)76:1 〈106::AID- CNCR2820760116〉3.0.CO;2-W)
47. Yao JC, Eisner MP, Leary C, Dagohoy C, Phan A, Rashid A, Hassan M & Evans DB 2007 Population-based study of islet cell carcinoma. Annals of Surgical Oncology 14 3492-3500. (doi:10.1245/s10434-007-9566-6) (Pubitemid 350160130)
48. Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, Abdalla EK, Fleming JB, Vauthey JN, Rashid A et al. 2008 One hundred years after 'carcinoid': epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. Journal of Clinical Oncology 26 3063-3072. (doi:10.1200/JCO.2007.15.4377)
49. Younes RN & GETNE (Grupo de Estudo de Tumores Neuroendó crinos) 2008 Neuroendocrine tumors: a registry of 1,000 patients. Revista da Associação Médica Brasileira 54 305-307. (doi:10.1590/S0104-42302008000400014)